Bills · HR 5133
IN COMMITTEE· 119TH CONGRESS
House BillHR 5133Health
Patients’ Right to Know Their Medication Act of 2025
INTRO SEP 4· LAST ACTION SEP 4
READING
6MIN
COSPONSORS
11BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenMany people find it difficult to fully understand the instructions and potential risks associated with their prescription drugs, which can lead to mistakes in how they take their medicine. These errors can result in serious health issues, avoidable emergency room visits, and costly hospital stays. Currently, the patient information provided with prescriptions can be inconsistent, hard to read, or unavailable in a preferred format.
This bill aims to solve these problems by guaranteeing that every patient receives a standardized, easy-to-understand paper guide with their medication. If this bill becomes law, it could significantly improve patient safety by empowering individuals to make informed decisions about their health and reduce the number of adverse drug events. It could also lead to substantial savings in healthcare costs by preventing medication-related emergencies. If the bill does not pass, the current system, which often lacks consistent and accessible medication information, will continue, potentially perpetuating preventable harm and healthcare expenditures.
KEY PROVISIONS
5AI-extractedPROVISION 01
Requires the FDA to issue new regulations within one year for standardized patient medication information (PMI) for all prescription drugs.
This sets the legal foundation for ensuring consistent and reliable drug information is provided to patients.
PROVISION 02
Mandates that PMI be provided in a printed, paper format, using plain language, graphics, and a consistent, standardized format (like font size and color).
This ensures the information is accessible and easy for all patients to understand, regardless of their digital access or literacy.
PROVISION 03
Specifies that the PMI must include comprehensive content, such as drug indications, general directions for use, contraindications, warnings, adverse reactions, drug interactions, and manufacturer contact details.
This guarantees that patients receive all crucial safety and usage information in a single, reliable source.
PROVISION 04
Makes drug manufacturers responsible for developing the PMI, which must be scientifically accurate, patient-friendly, and approved by the FDA as part of the drug application process.
This integrates patient safety information directly into the drug approval process, ensuring its accuracy and reliability.
PROVISION 05
Stipulates that a drug is considered "misbranded" if the required patient medication information is not provided with each prescription.
This creates a legal enforcement mechanism to ensure compliance with the new requirements.
SPONSORSHIP
1 + 11
R· Oregon
YRS IN OFFICE
5
BILLS LED
15
COSPONSOR BREAKDOWNBIPARTISAN · 91%
DEM 6 REP 5 IND 0
ACTION TIMELINE
2 EVENTSSEP 4
Introduced in House
SEP 4
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 5133
Congress119th
StatusIn Committee
IntroducedSep 4, 2025
Last actionSep 4, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED SEP 4, 2025
House BillHR 5133Health
Patients’ Right to Know Their Medication Act of 2025
INTRODUCED SEP 4, 2025· LAST ACTION SEP 4, 2025
PASSAGE CHANCES
—%
READING
6 min
COSPONSORS
11
COMPLEXITY
Moderate
